TAMIFLU (OSELTAMIVIR PHOSPHATE) MARKET ANALYSIS

Tamiflu (Oseltamivir Phosphate) Market, by Drug Type (Branded and Generic), by Dosage Form (Capsules and Suspension), by Indication (Influenza A, Influenza B, and Swine Flu (H1N1 Influenza A)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023
Code : CMI5489
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Tamiflu (Oseltamivir Phosphate) MarketSize and Trends

Global Tamiflu (oseltamivir phosphate) market is estimated to be valued at US$ 889.2 million in 2022 and is expected to exhibit a CAGR of 1.2% during the forecast period (2022-2030).

Figure 1.Global Tamiflu (Oseltamivir Phosphate) Market Share (%), by Drug Type, 2022

Global Tamiflu (Oseltamivir Phosphate) Market- Driver

The increasing prevalence of diseases such as influenza A, influenza B, and Others

Tamiflu (oseltamivir phosphate) is indicated for the treatment of influenza A, influenza B, and Swine Flu (H1N1 influenza). The increasing prevalence of influenza, globally, is expected to increase the growth of the global Tamiflu (oseltamivir phosphate) market, over the forecast period. For instance, in November 2021, according to an article published by the World Health Organization, in the year 2020, the global prevalence of influenza was 3 to 5 million cases of severe illness.

Market- Trends

Moreover, according to the Center for Disease Control and Prevention, October 2022, published incidence rates in percentage (%) for influenza for the seasons in 2017- 2018, 2018 - 2019 and 2019-2020 for different age groups in the U.S.